“Dangers of Chiral Class Drugs: Ibuprofen” (2025) Drug Discovery and Molecular Docking (DDMD), 1(2), pp. 16–22. Available at: https://ddmd.nknpub.com/1/article/view/8 (Accessed: 3 October 2025).